Publicacions en col·laboració amb investigadors/es de Universidad CEU San Pablo (12)

2024

  1. Correction to: Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release (Drug Delivery and Translational Research, (2024), 14, 4, (959-969), 10.1007/s13346-023-01444-2)

    Drug Delivery and Translational Research

  2. Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release

    Drug Delivery and Translational Research, Vol. 14, Núm. 4, pp. 959-969

2023

  1. Diseño de formulaciones para terapia combinada frente alglioblastoma

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Micropartículas biodegradables de metronidazol-sílice paratratamiento de amebiasis

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Micropartículas de Celecoxib-PLGA para el tratamiento de procesos inflamatorios pulmonares

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2022

  1. Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain

    Pharmaceutics, Vol. 14, Núm. 11

2021

  1. Sulfasalazine microparticles targeting macrophages for the treatment of inflammatory diseases affecting the synovial cavity

    Pharmaceutics, Vol. 13, Núm. 7

2020

  1. Potential Active Targeting of Gatifloxacin to Macrophages by Means of Surface-Modified PLGA Microparticles Destined to Treat Tuberculosis

    AAPS PharmSciTech, Vol. 21, Núm. 1

2013

  1. Development and validation of a reversed-phase liquid chromatography method for the quantification of meloxicam in liposomes

    Acta Chromatographica, Vol. 25, Núm. 4, pp. 639-653

2010

  1. Effective antiproliferative effect of meloxicam on prostate cancer cells: Development of a new controlled release system

    International Journal of Pharmaceutics, Vol. 387, Núm. 1-2, pp. 223-229

2008

  1. PLGA/PEG-derivative polymeric matrix for drug delivery system applications: Characterization and cell viability studies

    International Journal of Pharmaceutics, Vol. 352, Núm. 1-2, pp. 50-57

2004

  1. Time delay avoids interaction between guar gum and sulphadiazine after oral administration

    Journal of Drug Delivery Science and Technology, Vol. 14, Núm. 5, pp. 395-399